Carl-HenrikHeldin Uppsala UniversitySweden

Carl-Henrik Heldin is Chairman of the Board for the Nobel Foundation, and a molecular biologist and medical researcher. He has been director of the Uppsala branch of Ludwig Cancer Research since 1986 and professor in molecular cell biology at the medical faculty of Uppsala University since 1992.

Wednesday 10 June 2026

Time	Session

09:20 10:55	Symposium: Tumour Innervation Targeting the pro-tumorigenic effects of TGFb in tumor treatment Carl-HenrikHeldin Speaker Sweden Proffered Paper: Selected from Abstracts - to be announced in 2026 The role of neurons in carcinomas AndreasTrumpp Speaker Germany Proffered Paper: Selected from Abstracts - to be announced in 2026 Proffered Paper: Selected from Abstracts - to be announced in 2026 Pulmonary innervation impacts tumour progression: A tale of two cancers LeanneLi Speaker United Kingdom Room F6+7+8

Time

Session

09:20

10:55

Symposium: Tumour Innervation

Targeting the pro-tumorigenic effects of TGFb in tumor treatment

Carl-HenrikHeldin Speaker Sweden
Proffered Paper: Selected from Abstracts - to be announced in 2026
The role of neurons in carcinomas

AndreasTrumpp Speaker Germany
Proffered Paper: Selected from Abstracts - to be announced in 2026
Proffered Paper: Selected from Abstracts - to be announced in 2026
Pulmonary innervation impacts tumour progression: A tale of two cancers

LeanneLi Speaker United Kingdom

Room F6+7+8